Swedish Orphan Biovitrum AB (publ) (BIOVF) Investment Research Dashboard
About Swedish Orphan Biovitrum AB (publ) (BIOVF) stock analysis
Get live BIOVF stock price $48.20, comprehensive Swedish Orphan Biovitrum AB (publ) stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BIOVF stock data and investment insights.
Loading chart data...
Swedish Orphan Biovitrum AB (publ) (BIOVF) Overview
Swedish Orphan Biovitrum AB (publ) (BIOVF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, BIOVF trades at $48.20 with a market capitalization of 16.74B . Over the past 52 weeks, BIOVF has traded between $28.93 and $49.03 , with the current price positioned at approximately 96% ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 16.74B
- Current price: $48.20
- 52-week range: $28.93 - $49.03
- P/E ratio: 24.98
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating under the ticker BIOVF, Swedish Orphan Biovitrum AB (publ) is a specialized biotechnology company dedicated to the research, development, manufacturing, and commercialization of pharmaceutical products. Its primary therapeutic focus areas e...
Company Information
- CEO
- Guido Oelkers
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1969
Contact Information
- Website
- https://www.sobi.com
- Address
- Norra Stationsgatan 93A
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 25.0)
✓ Lower volatility stock (Beta: 0.29) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Swedish Orphan Biovitrum AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Swedish Orphan Biovitrum AB (publ)
- ⚠Investors should consider how Swedish Orphan Biovitrum AB (publ) fits within their overall portfolio allocation
Market Cap
16.74B
P/E Ratio (TTM)
24.98
Beta
0.29
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BIOVF with peer companies:
- Price
- $23.30-0.45% (1D)
- Market cap
- 9.26B
- Price
- $1.07+0.00% (1D)
- Market cap
- 12.20B
- Price
- $4.30+0.00% (1D)
- Market cap
- 12.39B
- Price
- $76.79-0.82% (1D)
- Market cap
- 13.27B
- Price
- $7.32+1.53% (1D)
- Market cap
- 8.26B
- Price
- $25.00-4.51% (1D)
- Market cap
- 7.05B
- Price
- $10.45+1.95% (1D)
- Market cap
- 7.11B
- Price
- $82.75+0.00% (1D)
- Market cap
- 11.66B
- Price
- $58.00+0.00% (1D)
- Market cap
- 11.80B
- Price
- $2.20+0.00% (1D)
- Market cap
- 5.82B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
80/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.